Advertisement
Screener

Standard BioTools Inc. (LAB) Material Contracts, 2020

Standard BioTools Inc. Material Contracts

Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.

  • 2020-11-09: Form 10-Q; Exhibit 10.6; Description Letter Agreement between President and Fellows of Harvard College and the registrant dated December 22, 2004..
  • 2020-11-09: Form 10-Q; Exhibit 10.5; Description Co-Exclusive License Agreement between President and Fellows of Harvard College and the registrant effective as of October 15, 2000..
  • 2020-11-09: Form 10-Q; Exhibit 10.4; Description Co-Exclusive License Agreement between President and Fellows of Harvard College and the registrant effective as of October 15, 2000..
  • 2020-11-09: Form 10-Q; Exhibit 10.3; Description Co-Exclusive License Agreement between President and Fellows of Harvard College and the registrant effective as of October 15, 2000..
FiledFormExhibitDescription
2020-11-0910-Q10.6Letter Agreement between President and Fellows of Harvard College and the registrant dated December 22, 2004.
2020-11-0910-Q10.5Co-Exclusive License Agreement between President and Fellows of Harvard College and the registrant effective as of October 15, 2000.
2020-11-0910-Q10.4Co-Exclusive License Agreement between President and Fellows of Harvard College and the registrant effective as of October 15, 2000.
2020-11-0910-Q10.3Co-Exclusive License Agreement between President and Fellows of Harvard College and the registrant effective as of October 15, 2000.
2020-11-0910-Q10.3AFirst Amendment to Co-Exclusive License Agreement between President and Fellows of Harvard College and the registrant effective as of October 15, 2000.
2020-11-0910-Q10.2Second Amended and Restated License Agreement between California Institute of Technology and the registrant effective as of May 1, 2004.
2020-11-0910-Q10.2AFirst Addendum, effective as of March 29, 2007, to Second Amended and Restated License Agreement between California Institute of Technology and the registrant effective as of May 1, 2004.
2020-11-0910-Q10.1Contract by and between the National Institutes of Health and the registrant effective as of July 30, 2020, as amended September 28, 2020.
2020-08-0710-Q10.5Fluidigm Corporation 2020 Change of Control and Severance Plan.
2020-06-248-K10.2Fluidigm Corporation 2011 Equity Incentive Plan, as amended effective June 23, 2020.
2020-06-248-K10.1Fluidigm Corporation 2017 Employee Stock Purchase Plan, as amended and restated effective June 23, 2020.
2020-04-228-K10.1Third Amendment to Loan and Security Agreement, dated April 21, 2020, between the Company and Silicon Valley Bank.
2020-02-2710-K10.13ADefault Waiver and First Amendment to Loan and Security Agreement, dated September 1, 2018, between the Company and Silicon Valley Bank.

Similar stocks

Stock NameCountryMarket CapPE Ratio
ROCKET PHARMACEUTICALS, INC. (RCKT)United States$0.296B-21.78
Vanda Pharmaceuticals Inc. (VNDA)United States$0.302B-1.35
Fulcrum Therapeutics, Inc. (FULC)United States$0.289B-3.28
Contineum Therapeutics, Inc. (CTNM)United States$0.289B-4.40
GT Biopharma, Inc. (GTBP)United States$0.309B-4.58
Perspective Therapeutics, Inc. (CATX)United States$0.284B-3.34
Upstream Bio, Inc. (UPB)United States$0.284B-2.42
ABEONA THERAPEUTICS INC. (ABEO)United States$0.312B-5.63
Sagimet Biosciences Inc. (SGMT)United States$0.279B
Prelude Therapeutics Inc (PRLD)United States$0.318B-7.01